학술논문
415P Patterns of time-to-progression intervals across clinical and liquid biopsy (LB) features in hormone receptor-positive (HR+) HER2-negative (HER2-) metastatic breast cancer (MBC) patients (pts) treated with first-line endocrine therapy (ET)
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S357-S357
Subject
Language
ISSN
0923-7534